Insider Trading History of Mannino Raphael J

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Mannino Raphael J since 2007. The trader's CIK number is 1196697. At the time of the last reporting, Mannino Raphael J was the Executive VP & CSO of Matinas Biopharma Holdings, Inc.. (stock ticker symbol MTNB). Also see all insider trading activities at Matinas Biopharma Holdings, Inc..

Note that in the past MANNINO RAPHAEL J also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Biodelivery Sciences International Inc (BDSI) by Mannino Raphael J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 BDSI 0 $0 0 $0 60,000 $97,800
2007 BDSI 0 $0 20,000 $99,527 20,000 $34,000

Yearly summary of insider trading at Matinas Biopharma Holdings, Inc. (MTNB) by Mannino Raphael J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 MTNB 5,000 $7,050 0 $0 0 $0


Insider trading activities at 2 companies by Mannino Raphael J:

1. Biodelivery Sciences International Inc (BDSI)

2. Matinas Biopharma Holdings, Inc. (MTNB)

Table 1. Insider trading of Biodelivery Sciences International Inc (BDSI) by Mannino Raphael J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-01-31 BDSI Option Ex 60,000 1.63 97,800
2007-06-25 BDSI Option Ex 20,000 1.70 34,000
2007-06-12 BDSI Sale 5,197 4.82 25,054
2007-06-06 BDSI Sale 14,803 5.03 74,473

Table 2. Insider trading of Matinas Biopharma Holdings, Inc. (MTNB) by Mannino Raphael J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-09-11 MTNB Buy 5,000 1.41 7,050

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mannino Raphael J (Executive VP & CSO of Matinas Biopharma Holdings, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.